4.5 Editorial Material

Recent Trends in Clinical Trials Related to Carrier-Based Drugs

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 106, Issue 9, Pages 2219-2226

Publisher

WILEY
DOI: 10.1016/j.xphs.2017.02.026

Keywords

clinical trials; drug delivery; nanoparticles; microparticles; carriers; liposomes; emulsions; micelles; polymers

Ask authors/readers for more resources

Clinical trials related to carrier-based drugs have recently attracted attention because carrier-based drugs hold promise for high efficiency drug delivery and for reducing drug-related side effects. In this commentary, we introduce recent clinical trials involving the use of various carriers, including liposomes, nano and micro particles, micelles, emulsions, and polymeric carriers. Liposomal drug carriers are currently the most intensively tested carriers in clinical trials, but other carriers such as polymeric carriers, albumin-based carriers, and metal nanocarriers have also recently been studied in clinical trials. Each carrier has specific properties, advantages, and disadvantages. The recent clinical trials introduced herein provide information critical to understanding current trends in carrier-based drug research. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available